# LEQSELVI
> **NDA217900** · New Drug Application · Sponsor: SUN PHARM INDS INC · Approved 2024-07-25
## Drug
- **FDA Application Number:** NDA217900
- **Application type:** New Drug Application
- **Brand name:** LEQSELVI
- **Generic name:** DEURUXOLITINIB PHOSPHATE
- **Active ingredients:** DEURUXOLITINIB PHOSPHATE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** SUN PHARM INDS INC
- **Manufacturer:** Sun Pharmaceutical Industries, Inc.
- **First approval:** 2024-07-25
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217900)
---
*MORVS · CC0 1.0*